← Eichor
Condition: Cushing Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cushing Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
Phase N/A · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06962202Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Phase N/A · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT07703683Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06635629Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02830308Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disea
Phase N/A · 1 location(s) · Mayo Clinic · NCT07335315A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
NA · 1 location(s) · Zhe Meng · NCT06250699Study of the Steroid Hormone Milieu in Obese Patients
Phase N/A · 1 location(s) · Istituto Auxologico Italiano · NCT06341699Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hyperco
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05911620Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
Phase 4 · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06801249Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitar
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07463625FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07460232Cushing's Syndrome Before and After Treatment (CORRECT)
Phase N/A · 1 location(s) · University of Aarhus · NCT05521529Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
Phase N/A · 1 location(s) · Shanghai 6th People's Hospital · NCT07156370Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
Phase N/A · 1 location(s) · Haukeland University Hospital · NCT06495983A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Crinetics Pharmaceuticals Inc. · NCT05804669Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Phase 2 · 1 location(s) · University of California, Los Angeles · NCT05971758Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Phase 2 · 1 location(s) · Cedars-Sinai Medical Center · NCT03774446Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrom
Phase 2 · 15 location(s) · RECORDATI GROUP · NCT03708900REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07412782Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
Phase N/A · 1 location(s) · Shanghai 6th People's Hospital · NCT07168122Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
Phase N/A · 1 location(s) · Mayo Clinic · NCT04543253Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04127552Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Phase 4 · 1 location(s) · Johns Hopkins University · NCT07247058DDAVP for Pituitary Adenoma
NA · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT04569591Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02019706A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Phase N/A · 1 location(s) · University of Michigan · NCT06430528An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT00001595A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
Phase 2 · 27 location(s) · H. Lundbeck A/S · NCT06471829Adrenal Tumors - Pathogenesis and Therapy
Phase N/A · 1 location(s) · University of Wuerzburg · NCT00669266
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.